Skip to content

Clinical trials

Cardiovascular Diseases trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Country / region: New Zealand Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20061
20071
20083
20093
20102
20113
20125
20134
20143
20151
20164
20172
20182
20201
20221
20245
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Recruiting5
Terminated5
Active, not recruiting3
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
GlaxoSmithKline3
Pfizer3
480 Biomedical2
Amgen2
Boehringer Ingelheim2
Cardurion Pharmaceuticals, Inc.2
Neuroscience Trials Australia2
The George Institute2
Verve Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases48
Heart Diseases13
Atherosclerosis9
Vascular Diseases9
Myocardial Infarction7
Coronary Artery Disease6
Diabetes Mellitus, Type 26
Hypertension6
Peripheral Arterial Disease6
Stroke6

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.